EN | TR
E-ISSN: 1307-5608
Central Retinal Vein Occlusion Following Intravenous Immunoglobulin Treatment in a Patient with Pemphigus Vulgaris
PDF
Cite
Share
Request
Case Report
VOLUME: 70 ISSUE: 1
P: 53-56
April 2017

Central Retinal Vein Occlusion Following Intravenous Immunoglobulin Treatment in a Patient with Pemphigus Vulgaris

J Ankara Univ Fac Med 2017;70(1):53-56
DOI: 10.1501/Tipfak_0000000963
Müzeyyen Gönül 1
Damla Atacan 1
Müge Pınar Özdal 2
Aysun Șanal Doğan 3
1. Sağlık Bilimleri University, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Dermatology Clinic, Ankara, Turkey
2. Saglik Bilimleri University, Ulucanlar Eye Training and Research Hospital, Ophthalmology Clinic, Ankara, Turkey
3. Sağlık Bilimleri University, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ophthalmology Clinic, Ankara, Turkey
No information available.
No information available
Received Date: 10.01.2017
Accepted Date: 30.05.2016
PDF
Cite
Share
Request

ABSTRACT

A 68-year-old male has been treated with prednisolone and intravenous immunoglobulin (IVIG) therapies with the diagnosis of pemphigus vulgaris. When he applied to receive the fifth session of IVIG therapy, he complained about visual loss. On the ophthalmologic examination, left central retinal vein occlusion (CRVO) was determined. There was no other detected underlying cause for CRVO and it was thought that central retinal vein thrombosis might be due to IVIG therapy.

IVIG treatment is generally accepted reliable for pemphigus vulgaris. However, it can rarely cause serious side effects like thrombosis. In literature, there are a few cases of central retinal vein occlusion due to IVIG therapy and none of these have dermatological disease as their etiology.

Keywords:
Central Retinal Vein Occlusion, Intravenous Immunoglobulin, Pemphigus Vulgaris